Kymera Therapeutics financials
$110.51−1.33%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $39.2M | $47.1M | $78.6M | $46.8M | $72.8M | $34.0M |
| Gross profit | $39.2M | $47.1M | $78.6M | $46.8M | $72.8M | $34.0M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$349.4M | -$261.6M | -$165.5M | -$161.3M | -$100.5M | -$46.3M |
| Net income | -$311.4M | -$223.9M | -$147.0M | -$154.8M | -$100.2M | -$54.6M |
| Net margin | −794.0% | −475.6% | −187.0% | −330.6% | −137.6% | −160.6% |
| Diluted EPS | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 |
| EBITDA | -$337.2M | -$249.3M | -$162.0M | -$161.3M | -$98.1M | -$44.5M |
| Operating cash flow | -$232.9M | -$194.5M | -$102.8M | -$153.1M | -$128.9M | $88.1M |
| Free cash flow | -$234.3M | -$207.3M | -$137.3M | -$155.9M | -$130.5M | $79.0M |
| Diluted shares | 84.5M | 75.0M | 58.4M | 53.9M | 48.0M | 17.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $357.0M | $120.3M | $110.0M | $68.4M | $48.0M | $31.0M |
| Short-term investments | $491.3M | $368.5M | $264.9M | $338.8M | $394.4M | $265.2M |
| Total debt | $3.3M | $3.7M | $2.6M | $2.7M | $2.3M | $1.3M |
| Total assets | $1.74B | $978.0M | $575.8M | $603.1M | $605.9M | $487.2M |
| Total liabilities | $163.1M | $142.4M | $180.8M | $113.0M | $146.3M | $203.3M |
| Shareholders' equity | $1.58B | $835.6M | $395.0M | $490.2M | $459.6M | $283.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology